PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma

Abstract Background Immune checkpoint blockade targeting PD-1/PD-L1 has shown efficacy in several types of cancers. However, the correlation between PD-L1/PD-1 expression and the specific clinicopathological features in papillary thyroid carcinoma (PTC) has not been investigated. Methods We examined...

Full description

Bibliographic Details
Main Authors: Yanhua Bai, Dongfeng Niu, Xiaozheng Huang, Ling Jia, Qiang Kang, Fangyuan Dou, Xinqiang Ji, Weicheng Xue, Yiqiang Liu, Zhongwu Li, Qin Feng, Dongmei Lin, Kennichi Kakudo
Format: Article
Language:English
Published: BMC 2017-10-01
Series:Diagnostic Pathology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13000-017-0662-z
id doaj-7d2eebdfbdaa42e29bbbb36d9e834765
record_format Article
spelling doaj-7d2eebdfbdaa42e29bbbb36d9e8347652020-11-25T00:44:41ZengBMCDiagnostic Pathology1746-15962017-10-011211810.1186/s13000-017-0662-zPD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinomaYanhua Bai0Dongfeng Niu1Xiaozheng Huang2Ling Jia3Qiang Kang4Fangyuan Dou5Xinqiang Ji6Weicheng Xue7Yiqiang Liu8Zhongwu Li9Qin Feng10Dongmei Lin11Kennichi Kakudo12Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Medical Statistics, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & InstituteDepartment of Pathology, Nara Hospital, Kindai University Faculty of MedicineAbstract Background Immune checkpoint blockade targeting PD-1/PD-L1 has shown efficacy in several types of cancers. However, the correlation between PD-L1/PD-1 expression and the specific clinicopathological features in papillary thyroid carcinoma (PTC) has not been investigated. Methods We examined the immunohistochemical expression of PD-L1, PD-1, and BRAF V600E on whole-tissue sections from 126 cases of primary PTC more than 1 cm in size. The correlation between the PD-L1/PD-1 expression and the clinicopathological features was evaluated. Results PD-L1 was positively expressed in 53.2% PTCs, and its expression was positively correlated with rich tumor-infiltrating lymphocytes (TILs), background chronic lymphocytic thyroiditis (CLT), female gender, absence of psammoma bodies, and PD-1 expression. Among these parameters, rich TILs, female gender, and absence of psammoma bodies were independent factors affecting PD-L1 expression on the multivariate logistic regression analysis. PD-1 expression was detected in the TILs and was positively correlated with rich TILs, background CLT, and absence of stromal calcification. Lack of stromal calcification was an independent factor affecting PD-1 expression. Neither PD-L1 nor PD-1 expression showed significant correlation with BRAF V600E expression. Conclusions Our results show that the distinctive pathological features of PTCs, including TILs, background CLT, female gender, psammoma bodies, and stromal calcification, are useful parameters for predicting PD-L1 or PD-1 expression.http://link.springer.com/article/10.1186/s13000-017-0662-zBRAF V600EChronic lymphocytic thyroiditisPapillary thyroid carcinomaPD-1PD-L1Tumor-infiltrating lymphocytes
collection DOAJ
language English
format Article
sources DOAJ
author Yanhua Bai
Dongfeng Niu
Xiaozheng Huang
Ling Jia
Qiang Kang
Fangyuan Dou
Xinqiang Ji
Weicheng Xue
Yiqiang Liu
Zhongwu Li
Qin Feng
Dongmei Lin
Kennichi Kakudo
spellingShingle Yanhua Bai
Dongfeng Niu
Xiaozheng Huang
Ling Jia
Qiang Kang
Fangyuan Dou
Xinqiang Ji
Weicheng Xue
Yiqiang Liu
Zhongwu Li
Qin Feng
Dongmei Lin
Kennichi Kakudo
PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
Diagnostic Pathology
BRAF V600E
Chronic lymphocytic thyroiditis
Papillary thyroid carcinoma
PD-1
PD-L1
Tumor-infiltrating lymphocytes
author_facet Yanhua Bai
Dongfeng Niu
Xiaozheng Huang
Ling Jia
Qiang Kang
Fangyuan Dou
Xinqiang Ji
Weicheng Xue
Yiqiang Liu
Zhongwu Li
Qin Feng
Dongmei Lin
Kennichi Kakudo
author_sort Yanhua Bai
title PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
title_short PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
title_full PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
title_fullStr PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
title_full_unstemmed PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
title_sort pd-l1 and pd-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
publisher BMC
series Diagnostic Pathology
issn 1746-1596
publishDate 2017-10-01
description Abstract Background Immune checkpoint blockade targeting PD-1/PD-L1 has shown efficacy in several types of cancers. However, the correlation between PD-L1/PD-1 expression and the specific clinicopathological features in papillary thyroid carcinoma (PTC) has not been investigated. Methods We examined the immunohistochemical expression of PD-L1, PD-1, and BRAF V600E on whole-tissue sections from 126 cases of primary PTC more than 1 cm in size. The correlation between the PD-L1/PD-1 expression and the clinicopathological features was evaluated. Results PD-L1 was positively expressed in 53.2% PTCs, and its expression was positively correlated with rich tumor-infiltrating lymphocytes (TILs), background chronic lymphocytic thyroiditis (CLT), female gender, absence of psammoma bodies, and PD-1 expression. Among these parameters, rich TILs, female gender, and absence of psammoma bodies were independent factors affecting PD-L1 expression on the multivariate logistic regression analysis. PD-1 expression was detected in the TILs and was positively correlated with rich TILs, background CLT, and absence of stromal calcification. Lack of stromal calcification was an independent factor affecting PD-1 expression. Neither PD-L1 nor PD-1 expression showed significant correlation with BRAF V600E expression. Conclusions Our results show that the distinctive pathological features of PTCs, including TILs, background CLT, female gender, psammoma bodies, and stromal calcification, are useful parameters for predicting PD-L1 or PD-1 expression.
topic BRAF V600E
Chronic lymphocytic thyroiditis
Papillary thyroid carcinoma
PD-1
PD-L1
Tumor-infiltrating lymphocytes
url http://link.springer.com/article/10.1186/s13000-017-0662-z
work_keys_str_mv AT yanhuabai pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma
AT dongfengniu pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma
AT xiaozhenghuang pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma
AT lingjia pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma
AT qiangkang pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma
AT fangyuandou pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma
AT xinqiangji pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma
AT weichengxue pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma
AT yiqiangliu pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma
AT zhongwuli pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma
AT qinfeng pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma
AT dongmeilin pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma
AT kennichikakudo pdl1andpd1expressionarecorrelatedwithdistinctiveclinicopathologicalfeaturesinpapillarythyroidcarcinoma
_version_ 1725274141334962176